Wavemaker Three-Sixty Health, a Pasadena, CA-based venture fund focused on early-stage (primarily seed) healthcare disruptors, raised $64M in Fund II.
Fund II’s Limited Partners (LPs) include hundreds of healthcare organizations and prominent healthcare executives across the United States, as well as some international investors.
The vehicle aims to invest into 40-50 early-stage companies (U.S. and to a lesser extent international).
Led by John Nackel, PhD, Founder and General Partner, and Jay Goss, General Partner, Wavemaker Three-Sixty Health (Wavemaker 360) is a seed-stage healthcare pure-play venture firm focused on disruptors in the areas of health-tech, digital health, medical device, telehealth, artificial intelligence, pharma-tech, science and marketplaces. Wavemaker 360 discovers, vets and invests solely in healthcare startups at the seed funding stage. The firm connects its portfolio companies to a network of 300 Limited Partners (LPs), comprised of healthcare entities and executives in virtually every area of healthcare.
In addition to its healthcare-focused LP network, Wavemaker 360 also includes a Council of Strategic Advisors comprised of executive-level professionals spanning an array of verticals in the healthcare industry including health systems administration, provider economics, government sponsored healthcare, healthcare staffing, digital health and beyond.
The firm currently has $85MM+ assets under management (AUM) across two funds, and in less than four years has invested into 45 healthcare companies across the U.S., Canada, Europe and Singapore. Of those companies, 15 are Fund II investments. One Fund II exit has already taken place, at an accelerated pace, with Carbon Health acquiring Alertive in October 2021.
FinSMEs
13/06/2022